Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway St., Baltimore, MD, 21205, USA.
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway St., Baltimore, MD, 21205, USA.
Harm Reduct J. 2023 Jun 1;20(1):69. doi: 10.1186/s12954-023-00795-w.
The opioid overdose crisis in the USA has called for expanding access to evidence-based substance use treatment programs, yet many barriers limit the ability of people who inject drugs (PWID) to engage in these programs. Predominantly rural states have been disproportionately affected by the opioid overdose crisis while simultaneously facing diminished access to drug treatment services. The purpose of this study is to explore barriers and facilitators to engagement in drug treatment among PWID residing in a rural county in West Virginia.
From June to July 2018, in-depth interviews (n = 21) that explored drug treatment experiences among PWID were conducted in Cabell County, West Virginia. Participants were recruited from locations frequented by PWID such as local service providers and public parks. An iterative, modified constant comparison approach was used to code and synthesize interview data.
Participants reported experiencing a variety of barriers to engaging in drug treatment, including low thresholds for dismissal, a lack of comprehensive support services, financial barriers, and inadequate management of withdrawal symptoms. However, participants also described several facilitators of treatment engagement and sustained recovery. These included the use of medications for opioid use disorder and supportive health care workers/program staff.
Our findings suggest that a range of barriers exist that may limit the abilities of rural PWID to successfully access and remain engaged in drug treatment in West Virginia. Improving the public health of rural PWID populations will require expanding access to evidence-based drug treatment programs that are tailored to participants' individual needs.
美国阿片类药物过量危机呼吁扩大获得循证物质使用治疗计划的机会,但许多障碍限制了注射毒品者(PWID)参与这些计划的能力。主要是农村州受到阿片类药物过量危机的不成比例影响,同时面临获得药物治疗服务的机会减少。本研究的目的是探讨居住在西弗吉尼亚州农村县的 PWID 参与药物治疗的障碍和促进因素。
2018 年 6 月至 7 月,在西弗吉尼亚州卡贝尔县对 PWID 的药物治疗经验进行了深入访谈(n=21)。参与者是从 PWID 经常光顾的地方招募的,如当地服务提供者和公共公园。采用迭代、修改的恒定比较方法对访谈数据进行编码和综合。
参与者报告了在参与药物治疗方面遇到的各种障碍,包括解雇的门槛低、缺乏全面的支持服务、经济障碍以及戒断症状管理不足。然而,参与者还描述了一些促进治疗参与和持续康复的因素。这些因素包括使用阿片类药物使用障碍的药物和支持性的医疗保健工作者/计划工作人员。
我们的研究结果表明,存在一系列障碍可能会限制西弗吉尼亚州农村 PWID 成功获得和持续参与药物治疗的能力。改善农村 PWID 人群的公共卫生需要扩大获得针对参与者个人需求的循证药物治疗计划的机会。